AMA Group (ASX:AMA) recovery is now being tested by whether cash flow can sustain the turnaround
AMA Group (ASX: AMA)’s recovery story is now being tested by whether improving earnings can translate into durable cash flow across its collision repair network, rather than fading as a short-term rebound. The business has moved beyond a pure survival narrative, but operating risks in parts of the network and still-soft repair volumes mean the next phase depends on execution rather than momentum.
Everything now depends on AMA proving that recent earnings gains reflect a structurally stronger business, not just favourable timing or temporary improvement.
That shift became clearer on 24 February, when the company reported first-half revenue up 6.0% to $524.1m, normalised pre-AASB 16 EBITDA up 21.9% to $30.5m, operating cash inflow after lease costs of $12.2m and maintained FY26 EBITDA guidance of $70m to $75m, giving the recovery more substance than earlier updates.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips
Earnings and cash flow are now moving in the same direction
AMA Group’s valuation now rests on whether stronger earnings can be matched by consistent cash generation. The February half-year result showed both improving at the same time, with revenue rising 6.0% to $524.1m, EBITDA increasing 21.9% to $30.5m and operating cash inflow after lease costs reaching $12.2m.
The more important detail was where that improvement originated. AMA Collision, previously a key weakness, delivered $6.1m of normalised pre-AASB 16 EBITDA, an $8.1m improvement on the prior period, while ACM Parts returned to positive EBITDA.
For a business that has spent several years rebuilding credibility, this begins to shift the narrative from survival toward whether operational improvements in utilisation, site economics and insurer work allocation can produce repeatable returns.
The market is reacting to proof rather than narrative
Over the past year, the share price has been shaped less by broad market conditions than by operating updates that either reinforced or challenged the turnaround story. The February result mattered because it linked stronger earnings to stronger cash flow while maintaining guidance, reducing concerns that earlier momentum might fade.
Earlier, the 31 October first-quarter update had shown EBITDA up 36.3% to $20.1m, but a $3.1m operating cash outflow caused by $8.7m of delayed receipts introduced doubt. The business appeared to be improving, but cash timing issues limited confidence.
The later half-year result addressed that concern by confirming the receipts had been realised and that net debt of $20.7m and covenant headroom remained manageable. Turnarounds tend to rerate only when profit and cash move together, and this sequence begins to meet that condition.
Network utilisation and repair mix drive underlying economics
AMA Group operates a multi-brand collision repair network including Capital SMART, AMA Collision, AMA Prestige, Wales Heavy Vehicle and specialist operations such as TechRight and TrackRight, alongside ACM Parts. Earnings depend on how effectively work is allocated across this network and how efficiently each site converts volume into margin.
The revenue base extends beyond basic collision repair to include drivable and non-drivable repairs, heavy vehicle work, prestige vehicle repairs, mechanical collision repairs, ADAS calibrations and the sale of collision and mechanical parts, consumables, reclaimed parts and genuine parts.
This matters because growth is driven by both volume and mix. More complex repairs typically command higher average repair prices, while integration with the parts business can improve margins and supply chain control.
Progress is visible, but past execution still shapes perception
The current share price reflects both tangible improvement and lingering scepticism. AMA Collision has improved materially, ACM Parts has returned to positive EBITDA and network changes are aimed at improving utilisation and site performance.
New Capital SMART sites at Wingfield, Newcastle and Hobart expand capacity, while selected closures in AMA Collision are designed to lift average site performance rather than maintain scale at the expense of returns.
However, short-term issues have persisted. System interruptions delayed receipts, Victoria has experienced softer claims and repair volumes, and Wales has faced weaker large crash repair volumes alongside more insurance write-offs. These factors explain why the market has not fully rewarded the recovery.
Margin durability is the key valuation driver
The central valuation question is whether AMA can convert recent earnings gains into sustainable margin expansion across its collision repair network. Management is targeting a 10% pre-AASB 16 EBITDA margin in core vehicle collision repair businesses over three to four years.
This target is significant because even modest improvements in margin can have a substantial impact in a business with high fixed site costs and purchasing leverage.
Investors are likely to respond positively if three conditions are met: FY26 guidance of $70m to $75m is delivered, new and expanded sites ramp efficiently, and weaker segments such as Wales and ACM Parts continue to improve.
Execution will determine whether the recovery holds
There is a credible upside case. Capacity expansion through new Capital SMART sites, planned growth in Sydney and Adelaide, continued improvement in AMA Collision and a target of 5,000 repairs per week all support potential growth.
Wales is expected to improve as large-scale repairs normalise, while Prestige, TechRight and TrackRight are also trending positively. These are tangible drivers rather than theoretical opportunities.
The downside remains equally clear. Lower repair volumes, higher write-offs, lease cost pressures and execution risk around site optimisation could interrupt the recovery. The next phase will determine whether AMA transitions into a business with reliable cash generation or remains a turnaround still proving its durability.
Blog Categories
Get the Latest Insider Trades on ASX!
Recent Posts
Radiopharm Theranostics (ASX: RAD) is increasingly defined by whether RAD101 can justify a registrational pathway
Radiopharm Theranostics (ASX:RAD) is increasingly defined by whether its lead imaging asset RAD101 can convert encouraging mid-stage data into a…
3P Learning (ASX:3PL) must arrest school churn to protect its valuation
3P Learning (ASX: 3PL)’s valuation now hinges on whether the business review can arrest B2B school churn and declining revenue…
IperionX (ASX: IPX) needs repeat Virginia orders to unlock its titanium platform value
IperionX (ASX: IPX) is now a trade-off between the cash-hungry ramp-up at its Virginia Titanium Manufacturing Campus and the longer-term…